Product Information
CITALOPRAM HBR 10 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0246 per EA under NDC 69097082212. Its NADAC has been published 509 times since Nov 23, 2016.
FDA first approved this application on Oct 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Cipla USA Inc.NDC
69097082212
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077534FDA Approved
10/3/2006
TE Code
AB
On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 10 MG TABLET has been published 509 times since Nov 23, 2016, and over the history we have for it it has declined 23.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0246 per EA |
|---|---|
| All-time high | $0.0359 (Jan 11, 2017) |
| All-time low | $0.0204 (May 22, 2024) |
| 52-week high | $0.0258 |
| 52-week low | $0.0240 |
| Median price | $0.0272 |
| Average price | $0.0274 |
| Largest weekly change | +24.2% (Jun 19, 2024) |
| Weeks tracked | 509 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 10 MG TABLET, manufactured by Cipla USA Inc., is $0.0246 per EA (NDC 69097082212), effective Aug 19, 2026.
How has the price of CITALOPRAM HBR 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 10 MG TABLET has declined 23.5%. It has been tracked across 509 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 10 MG TABLET?
Since Nov 23, 2016, the NADAC for CITALOPRAM HBR 10 MG TABLET has ranged from a low of $0.0204 (May 22, 2024) to a high of $0.0359 (Jan 11, 2017), with a median of $0.0272 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 10 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CITALOPRAM HBR 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CITALOPRAM HBR 10 MG TABLET?
CITALOPRAM HBR 10 MG TABLET (NDC 69097082212) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.